ResMed CEO sells 3,200 shares

Thursday, July 17, 2014

SAN DIEGO – ResMed CEO Michael Farrell sold 3,200 shares of company stock on the open market July 15. The stock was sold at an average $49.22 for a total transaction of $157,504, according to news reports. Farrell now owns 106,655 shares of ResMed stock, worth about $5.2 million.